High Perianal Abscess
Conditions
Interventions
Oral Group:Oral administration of XZKJD group. Patients took one dose per day of the XZKJD divided into three oral administrations of 200 ml each. Following routine disinfection during daily dressing
Control group:Patients in this group received routine normal saline irrigation and dressing changes, with no oral or topical fumigation of herbal medicine. Similar to the other groups, a 50 ml syringe
Topical Fumigation Group:Patients underwent topical fumigation with XZKJD for irrigation and dressing changes, with no oral intake of the herbal medicine. Following routine disinfection during daily d
Sponsors
Hospital of Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1) Patients diagnosed with high grade perianal abscess (the diagnosis is heat-toxin-containing knot syndrome) and undergoing surgery for virtual and real hanging wire (multi-incision floating wire drainage); 2) Age between 18 and 60 years old; 3) Blood urine feces routine bleeding and coagulation time liver and kidney function blood glucose electrocardiogram are within the normal range; 4) Normal cognitive function with basic communication and exchange ability; 5) Good compliance to the researcher's observation and treatment Voluntary Participate in the clinical observation trial and sign the consent form; 6) Voluntarily participate in this project and sign the informed consent form.
Exclusion criteria
Exclusion criteria: The existence of any one of the following conditions are excluded: 1) tuberculosis leukemia trauma immune diseases Crohn's disease and inflammatory bowel disease and other specific perianal abscess; 2) combined with systemic diseases such as malignant neoplasms diabetes mellitus severe hypertension hematological system and other primary diseases; 3) combined with gastrointestinal disorders such as chronic constipation chronic diarrhea etc.; 4) serious heart brain liver lungs kidneys and other important organ diseases and mental illnesses; 5) combined with other anal diseases such as rectal prolapse anal eczema rectal polyps etc.; 6) previous patients with heart brain liver lung kidney and other major organ diseases and mental illnesses; 5) combined with other anal diseases such as prolapsed rectum Patients with severe heart brain liver lung kidney and other important organ diseases and mental diseases; 5) patients with other anal diseases such as rectal prolapse anal eczema rectal polyps etc.; 6) patients with a history of anal surgery or abnormal anal morphology and function; 7) patients with infectious diseases such as tuberculosis hepatitis B sexually transmitted diseases etc.; 8) women in pregnancy or breastfeeding; 9) patients who participate in other clinical experimental research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IL-6(Interleukin 6);IL-1ß(Interleukin 1 beta);TNF-a(Tumor Necrosis Factor-alpha); | — |
Secondary
| Measure | Time frame |
|---|---|
| Wound secretion;Wound healing;pain in the wound; | — |
Countries
China
Contacts
Public ContactHao Fu
Hospital of Chengdu University of Traditional Chinese Medicine
Outcome results
None listed